Skip to content

Adjustment Exploratory Protocols and Functional Evaluation of New Non Invasive Devices in Patient Volunteers

Adjustment Exploratory Protocols (MagnetoEncephaloGraphy Study : MEG, ElectroEncephaloGram : EEG, Magnetic Resonance Imaging : MRI, Functional MRI : MRIf, Motor Platform) and Functional Evaluation of New Non Invasive Devices (REX BIONICS Exoskeleton) in Patient Volunteers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02790424
Acronym
MAP-EFNI PV
Enrollment
35
Registered
2016-06-03
Start date
2013-10-22
Completion date
2021-10-22
Last updated
2022-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurological Diseases

Brief summary

Parameters, sequences or paradigms optimisation in view of data quality and relevancy improvement.

Detailed description

Various tests are needed for methodological optimization of the several devices (per-operative MRI, MEG, EEG, SPECT-CT, motor platform) of the technological platform.

Interventions

technological adjustment tests

Sponsors

University Hospital, Grenoble
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Volunteers patient * Male or female aged over 18 years * Registered in the French social security scheme * Signed informed consent

Exclusion criteria

* Contraindication to Magnetoencephalography (MEG) and/or Electroencephalography (EEG) * Contraindication to Magnetic resonance imaging (MRI) * All categories of protected persons

Design outcomes

Primary

MeasureTime frameDescription
Magnetic brain activity2 hoursMEG records
Brain imaging2 hoursMRI and SPECT-CT records
Electrical brain activity2 hoursEEG records
Motor activity parameters2 hoursMotor platform records

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026